Navigation Links
Executive Order on Embryonic Stem Cells 'A Sad Victory of Politics Over Science and Ethics,' Says Cardinal Rigali
Date:3/9/2009

WASHINGTON, March 9 /PRNewswire-USNewswire/ -- Cardinal Justin Rigali, chairman of the U.S. Conference of Catholic Bishops' Committee on Pro-Life Activities, today called President Obama's executive order on embryonic stem cell research "a sad victory of politics over science and ethics." Under the order, for the first time in U.S. history, federal tax dollars will be used to encourage researchers to destroy live human embryos for stem cell research. Cardinal Rigali also cited a January 16 letter in which Cardinal Francis George, president of the USCCB, urged President-elect Obama not to issue such an order. Cardinal Rigali's statement follows:

"President Obama's new executive order on embryonic stem cell research is a sad victory of politics over science and ethics. This action is morally wrong because it encourages the destruction of innocent human life, treating vulnerable human beings as mere products to be harvested. It also disregards the values of millions of American taxpayers who oppose research that requires taking human life. Finally, it ignores the fact that ethically sound means for advancing stem cell science and medical treatments are readily available and in need of increased support.

"In his January 16th letter to President-elect Obama, Cardinal George, writing as President of the USCCB, cited three reasons why such destructive research is 'especially pointless at this time':

  • 'First, basic research in the capabilities of embryonic stem cells can be and is being pursued using the currently eligible cell lines as well as the hundreds of lines produced with nonfederal funds since 2001.
  • 'Second, recent startling advances in reprogramming adult cells into embryonic-like stem cells - hailed by the journal Science as the scientific breakthrough of the year - are said by many scientists to be making embryonic stem cells irrelevant to medical progress.
  • 'Third, adult and cord blood stem cells are now known to have great versatility, and are increasingly being used to reverse serious illnesses and even help rebuild damaged organs. To divert scarce funds away from these promising avenues for research and treatment toward the avenue that is most morally controversial as well as most medically speculative would be a sad victory of politics over science.'

"If the government wants to invest in hope for cures and promote ethically sound science, it should use our tax monies for research that everyone, at every stage of human development, can live with."


'/>"/>
SOURCE U.S. Conference of Catholic Bishops Secretariat for Pro-Life Activities
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. University of Maryland Business School Continues Executive Education Leadership With Maryland State Medical Society Partnership
2. Pelosi Statement on President Obamas Executive Order on Stem Cell Research
3. Reveille Software Reaches Customer Milestone and Expands Executive Team
4. Embryonic Stem Cell Research Executive Order Places Politics Ahead of Science, Says Michigan Catholic Conference
5. National Patient Advocate Foundation Announces 2009 Elections of Health Policy Leaders to Executive Board of Directors
6. It Must Be Friday Night: Pres. Obama to Issue Deadly Executive Order
7. HMS Holdings Corp. Announces Executive Promotions
8. RoundTable Appoints Senior Healthcare Executives
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Authentidate Holding Corp.
10. Authentidate Holding Corp. Non-executive Chairman F. Ross Johnson Steps Down From Board of Directors
11. Statement by Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on the Presidents 2010 Budget Proposal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... ... , ... HMP , a leader in healthcare events and education, today announced ... Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie ... competition recognizes editorial and design excellence across a range of sectors. This year’s program ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in wound care advancements to physician colleagues, skilled nursing facility medical directors and ... the Treacherous Waters of Wound Care." , "At many of these conferences we ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... -- AVACEN Medical , Inc. (AVACEN) announced that Frost ... Product Innovation Award for Its fibromyalgia pain management device. ... device market research by Frost & Sullivan,s industry experts. ... relief product, the AVACEN 100, offers a safe and effective ... ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology: